Insider Trading April 3, 2026

Saba Capital Sells $4.2M in BlackRock ECAT Shares, Retains Over 21.7M Stake

Form 4 shows 303,392 ECAT shares sold at $13.87 across April 1-2, 2026 as the trust trades near a 52-week low

By Leila Farooq ECAT
Saba Capital Sells $4.2M in BlackRock ECAT Shares, Retains Over 21.7M Stake
ECAT

Saba Capital Management, L.P., identified as a ten-percent owner of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT), reported dispositions totaling 303,392 shares valued at $4.2 million in an SEC Form 4 filing. The sales occurred on April 1 and April 2, 2026, at $13.87 per share. After the April 1 transactions Saba's direct holdings stood at 21,762,781 shares; following the April 2 transactions those holdings were 21,718,771 shares. The trust yields 23.68% and is trading close to its 52-week low, with the most recent price at $13.85. The Form 4 was signed by David Han and Boaz Weinstein on April 3, 2026.

Key Points

  • Saba Capital sold 303,392 ECAT shares for roughly $4.2 million at $13.87 per share on April 1-2, 2026.
  • Direct holdings were 21,762,781 shares after April 1 trades and 21,718,771 shares after April 2 trades.
  • ECAT yields 23.68% and was trading near a 52-week low of $13.35 with a recent price of $13.85; sectors affected include closed-end funds, asset management, and income-focused investors.

Saba Capital Management, L.P. - listed as holding roughly ten percent of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT) - disclosed a series of share sales in a Form 4 filed with the Securities and Exchange Commission.

The filing shows Saba sold a combined total of 303,392 ECAT shares at a transaction price of $13.87 per share across April 1 and April 2, 2026, producing proceeds of approximately $4.2 million. The disposition on April 1 comprised 259,382 shares, and the April 2 activity accounted for an additional 44,010 shares.

Following the April 1 trades, Saba Capital Management directly held 21,762,781 shares of BlackRock ESG Capital Allocation Term Trust. After the additional disposition on April 2, the firm's direct ownership was recorded at 21,718,771 shares.

The sales occurred while ECAT was trading near its 52-week low of $13.35; the trust's most recently reported market price was $13.85. The closed-end trust offers a reported dividend yield of 23.68% and has drawn notable institutional attention.

The Form 4 filing was signed by David Han of Saba Capital Management L.P. and Boaz Weinstein on April 3, 2026. The filing documents the mechanics of the dispositions and the updated direct holdings reflected after each day's transactions.

Additional context in the filing notes institutional interest in the trust and highlights the trust's elevated yield. InvestingPro subscribers are noted as having access to five additional exclusive tips on ECAT together with detailed financial metrics.


Summary: Saba Capital reported the sale of 303,392 shares of BlackRock ESG Capital Allocation Term Trust at $13.87 per share on April 1-2, 2026, reducing its direct holdings to 21,718,771 shares as reflected in a Form 4 signed April 3, 2026. ECAT is trading close to its 52-week low and carries a 23.68% dividend yield.

Key points:

  • Saba Capital sold 303,392 ECAT shares for about $4.2 million at $13.87 per share across April 1 and April 2, 2026.
  • Direct holdings after April 1 transactions were 21,762,781 shares; after April 2 transactions holdings were 21,718,771 shares.
  • The trust is yielding 23.68% and was trading near a 52-week low of $13.35, with a recent price of $13.85. Sectors impacted include closed-end funds and income-focused investors, and market activity touches asset management and institutional investor behavior.

Risks and uncertainties:

  • Market-price risk: ECAT is trading near its 52-week low, which introduces downside price risk for current and prospective investors.
  • Ownership-profile change: The reported dispositions altered Saba Capital's direct holdings, which may change the institutional ownership concentration of the trust.
  • Unclear motives: The filing documents the transactions but does not disclose the reasons for the sales, leaving the intent behind the dispositions unspecified.

Risks

  • ECAT is trading close to its 52-week low, indicating market-price risk for investors and the fund.
  • The change in Saba Capital's holdings alters the ownership profile among institutional holders of the trust.
  • The Form 4 documents the sales but does not state the reasons behind the dispositions, leaving motives unclear.

More from Insider Trading

Gulfport Director Sells $85,360 in Stock as Company Navigates Earnings Miss and Buyback Activity Apr 3, 2026 Whitehawk Therapeutics CEO Sells $93,465 in Stock as Company Advances HWK-007 Program Apr 3, 2026 Heartflow CMO Campbell Rogers Sells $1.59M in Stock, Exercises Options Apr 3, 2026 SI-BONE CFO Sells 3,318 Shares, Raising $42,707 to Cover RSU Taxes Apr 3, 2026 Symbotic Chief Strategy Officer Disposes $286K in Class A Shares Under 10b5-1 Plan Apr 3, 2026